Menu

Blog

HomeNews and BlogsBlog
May 30, 2023

An increase in early-stage ovarian cancer detected in women using the ROCA test.

In November 2022, the Journal of Medical Genetics published a paper that presented the results of a pilot national ovarian cancer surveillance programme using the ROCA Test, for women with alterations in the BRCA1 and BRCA2 genes.
May 11, 2023

Ovarian Cancer Surveillance using the ROCA Test: The Evidence Explained

In November 2022, the Journal of Medical Genetics published a paper that presents the results of a pilot national surveillance programme using the ROCA Test, for women with alterations in the BRCA1 and BRCA2 genes. The study was called ALDO, meaning ‘Avoiding Late Diagnosis of Ovarian cancer’.